Contact Us

(206) 223-2319

Digestive Disease Quality Improvement

Deborah Tombs, RN, and DDI Quality Improvement Director, Otto Lin, MD, discuss propofol infusion dosing.
Deborah Tombs, RN, and DDI Quality Improvement Director, Otto Lin, MD, discuss propofol infusion dosing.

In addition to its focus on multidisciplinary care and research, the Digestive Disease Institute is committed to improving the health and well-being of the patients we serve through multiple quality improvement initiatives. Led by Director of Quality, Otto Lin, MD, these initiatives have drawn world wide attention to standard-setting care pathways and excellent survival outcomes for colon, esophageal and pancreatic cancer patients at Virginia Mason.

Providers at the Digestive Disease Institute are constantly pursuing quality improvement. Current initiatives include:

  • Developing and implementing protocols for enhancing follow-up care for liver and colon disease screening.
  • Collecting and analyzing data on colonoscopy completion rate for screening and surveillance patients.
  • Examining polyp (adenoma) detection rates for screening and surveillance patients.
  • Collecting and analyzing data on blood and lab values for patients with inflammatory bowel disease.

Often, analysis of data leads to new discoveries in digestive disease care, results in publication of findings from Digestive Disease Institute providers, and produces opportunities to benchmark ourselves according to local and national patient care volumes and standards.

Collecting and analyzing data in well-designed prospective and retrospective databases supports Digestive Disease Institute providers in making evidence-based decisions about frequency and type of treatment, facilitating innovative modes of therapy, and improving the care and experience of the patient. Data in current databases is used to study how to best address and treat:

For more information about quality improvement initiatives at the Digestive Disease Institute, please call (206) 223-2319.